#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


1-1	0-11	Dissociable	_
1-2	12-21	relations	_
1-3	22-29	between	_
1-4	30-38	amygdala	_
1-5	39-50	subregional	_
1-6	51-59	networks	_
1-7	60-63	and	_
1-8	64-75	psychopathy	_
1-9	76-81	trait	_
1-10	82-92	dimensions	_
1-11	93-95	in	_
1-12	96-114	conduct‐disordered	_
1-13	115-123	juvenile	_
1-14	124-133	offenders	_
1-15	134-142	Abstract	_
1-16	143-154	Psychopathy	_
1-17	155-157	is	_
1-18	158-159	a	_
1-19	160-167	serious	_
1-20	168-179	psychiatric	_
1-21	180-190	phenomenon	_
1-22	191-204	characterized	_
1-23	205-207	by	_
1-24	208-209	a	_
1-25	210-222	pathological	_
1-26	223-236	constellation	_
1-27	237-239	of	_
1-28	240-249	affective	_
1-29	250-251	(	_
1-30	252-256	e.g.	_
1-31	257-258	,	_
1-32	259-266	callous	_
1-33	267-268	,	_
1-34	269-280	unemotional	_
1-35	281-282	)	_
1-36	283-284	,	_
1-37	285-298	interpersonal	_
1-38	299-300	(	_
1-39	301-305	e.g.	_
1-40	306-307	,	_
1-41	308-320	manipulative	_
1-42	321-322	,	_
1-43	323-333	egocentric	_
1-44	334-335	)	_
1-45	336-337	,	_
1-46	338-341	and	_
1-47	342-352	behavioral	_
1-48	353-354	(	_
1-49	355-359	e.g.	_
1-50	360-361	,	_
1-51	362-371	impulsive	_
1-52	372-373	,	_
1-53	374-387	irresponsible	_
1-54	388-389	)	_
1-55	390-401	personality	_
1-56	402-408	traits	_
1-57	409-410	.	_

2-1	411-417	Though	_
2-2	418-426	amygdala	_
2-3	427-438	subregional	_
2-4	439-446	defects	_
2-5	447-450	are	_
2-6	451-460	suggested	_
2-7	461-463	in	_
2-8	464-475	psychopathy	_
2-9	476-477	,	_
2-10	478-481	the	_
2-11	482-495	functionality	_
2-12	496-499	and	_
2-13	500-512	connectivity	_
2-14	513-515	of	_
2-15	516-525	different	_
2-16	526-534	amygdala	_
2-17	535-544	subnuclei	_
2-18	545-547	is	_
2-19	548-557	typically	_
2-20	558-569	disregarded	_
2-21	570-572	in	_
2-22	573-591	neurocircuit‐level	_
2-23	592-600	analyses	_
2-24	601-603	of	_
2-25	604-616	psychopathic	_
2-26	617-628	personality	_
2-27	629-630	.	_

3-1	631-636	Hence	_
3-2	637-638	,	_
3-3	639-645	little	_
3-4	646-648	is	_
3-5	649-654	known	_
3-6	655-657	of	_
3-7	658-661	how	_
3-8	662-670	amygdala	_
3-9	671-682	subregional	_
3-10	683-691	networks	_
3-11	692-695	may	_
3-12	696-706	contribute	_
3-13	707-709	to	_
3-14	710-721	psychopathy	_
3-15	722-725	and	_
3-16	726-729	its	_
3-17	730-740	underlying	_
3-18	741-746	trait	_
3-19	747-757	assemblies	_
3-20	758-760	in	_
3-21	761-769	severely	_
3-22	770-780	antisocial	_
3-23	781-787	people	_
3-24	788-789	.	_

4-1	790-792	We	_
4-2	793-802	addressed	_
4-3	803-807	this	_
4-4	808-817	important	_
4-5	818-823	issue	_
4-6	824-826	by	_
4-7	827-835	uniquely	_
4-8	836-845	examining	_
4-9	846-849	the	_
4-10	850-859	intrinsic	_
4-11	860-870	functional	_
4-12	871-883	connectivity	_
4-13	884-886	of	_
4-14	887-898	basolateral	_
4-15	899-900	(	_
4-16	901-904	BLA	_
4-17	905-906	)	_
4-18	907-910	and	_
4-19	911-923	centromedial	_
4-20	924-925	(	_
4-21	926-929	CMA	_
4-22	930-931	)	_
4-23	932-940	amygdala	_
4-24	941-949	networks	_
4-25	950-952	in	_
4-26	953-961	relation	_
4-27	962-964	to	_
4-28	965-974	affective	_
4-29	975-976	,	_
4-30	977-990	interpersonal	_
4-31	991-992	,	_
4-32	993-996	and	_
4-33	997-1007	behavioral	_
4-34	1008-1014	traits	_
4-35	1015-1017	of	_
4-36	1018-1029	psychopathy	_
4-37	1030-1031	,	_
4-38	1032-1034	in	_
4-39	1035-1053	conduct‐disordered	_
4-40	1054-1063	juveniles	_
4-41	1064-1068	with	_
4-42	1069-1070	a	_
4-43	1071-1078	history	_
4-44	1079-1081	of	_
4-45	1082-1089	serious	_
4-46	1090-1101	delinquency	_
4-47	1102-1103	(	_
4-48	1104-1105	N	_
4-49	1106-1107	=	_
4-50	1108-1110	50	_
4-51	1111-1112	,	_
4-52	1113-1117	mean	_
4-53	1118-1121	age	_
4-54	1122-1123	=	_
4-55	1124-1129	16.83	_
4-56	1130-1131	±	_
4-57	1132-1136	1.32	_
4-58	1137-1138	)	_
4-59	1139-1140	.	_

5-1	1141-1143	As	_
5-2	1144-1153	predicted	_
5-3	1154-1155	,	_
5-4	1156-1165	amygdalar	_
5-5	1166-1178	connectivity	_
5-6	1179-1187	profiles	_
5-7	1188-1197	exhibited	_
5-8	1198-1209	dissociable	_
5-9	1210-1219	relations	_
5-10	1220-1224	with	_
5-11	1225-1234	different	_
5-12	1235-1241	traits	_
5-13	1242-1244	of	_
5-14	1245-1256	psychopathy	_
5-15	1257-1258	.	_

6-1	1259-1272	Interpersonal	_
6-2	1273-1285	psychopathic	_
6-3	1286-1292	traits	_
6-4	1293-1296	not	_
6-5	1297-1301	only	_
6-6	1302-1309	related	_
6-7	1310-1312	to	_
6-8	1313-1322	increased	_
6-9	1323-1335	connectivity	_
6-10	1336-1338	of	_
6-11	1339-1342	BLA	_
6-12	1343-1346	and	_
6-13	1347-1350	CMA	_
6-14	1351-1355	with	_
6-15	1356-1357	a	_
6-16	1358-1373	corticostriatal	_
6-17	1374-1381	network	_
6-18	1382-1391	formation	_
6-19	1392-1405	accommodating	_
6-20	1406-1412	reward	_
6-21	1413-1423	processing	_
6-22	1424-1425	,	_
6-23	1426-1429	but	_
6-24	1430-1434	also	_
6-25	1435-1444	predicted	_
6-26	1445-1453	stronger	_
6-27	1454-1457	CMA	_
6-28	1458-1470	connectivity	_
6-29	1471-1475	with	_
6-30	1476-1477	a	_
6-31	1478-1485	network	_
6-32	1486-1488	of	_
6-33	1489-1497	cortical	_
6-34	1498-1505	midline	_
6-35	1506-1516	structures	_
6-36	1517-1527	supporting	_
6-37	1528-1542	sociocognitive	_
6-38	1543-1552	processes	_
6-39	1553-1554	.	_

7-1	1555-1557	In	_
7-2	1558-1566	contrast	_
7-3	1567-1568	,	_
7-4	1569-1578	affective	_
7-5	1579-1591	psychopathic	_
7-6	1592-1598	traits	_
7-7	1599-1606	related	_
7-8	1607-1609	to	_
7-9	1610-1620	diminished	_
7-10	1621-1624	CMA	_
7-11	1625-1637	connectivity	_
7-12	1638-1642	with	_
7-13	1643-1644	a	_
7-14	1645-1657	frontolimbic	_
7-15	1658-1665	network	_
7-16	1666-1673	serving	_
7-17	1674-1682	salience	_
7-18	1683-1693	processing	_
7-19	1694-1697	and	_
7-20	1698-1707	affective	_
7-21	1708-1718	responding	_
7-22	1719-1720	.	_

8-1	1721-1728	Finally	_
8-2	1729-1730	,	_
8-3	1731-1741	behavioral	_
8-4	1742-1754	psychopathic	_
8-5	1755-1761	traits	_
8-6	1762-1769	related	_
8-7	1770-1772	to	_
8-8	1773-1783	heightened	_
8-9	1784-1787	BLA	_
8-10	1788-1800	connectivity	_
8-11	1801-1805	with	_
8-12	1806-1807	a	_
8-13	1808-1822	frontoparietal	_
8-14	1823-1830	cluster	_
8-15	1831-1841	implicated	_
8-16	1842-1844	in	_
8-17	1845-1855	regulatory	_
8-18	1856-1865	executive	_
8-19	1866-1877	functioning	_
8-20	1878-1879	.	_

9-1	1880-1882	We	_
9-2	1883-1890	suggest	_
9-3	1891-1895	that	_
9-4	1896-1901	these	_
9-5	1902-1916	trait‐specific	_
9-6	1917-1923	shifts	_
9-7	1924-1926	in	_
9-8	1927-1936	amygdalar	_
9-9	1937-1949	connectivity	_
9-10	1950-1955	could	_
9-11	1956-1958	be	_
9-12	1959-1971	particularly	_
9-13	1972-1980	relevant	_
9-14	1981-1983	to	_
9-15	1984-1987	the	_
9-16	1988-2000	psychopathic	_
9-17	2001-2010	phenotype	_
9-18	2011-2012	,	_
9-19	2013-2015	as	_
9-20	2016-2020	they	_
9-21	2021-2024	may	_
9-22	2025-2029	fuel	_
9-23	2030-2031	a	_
9-24	2032-2045	self‐centered	_
9-25	2046-2047	,	_
9-26	2048-2059	emotionally	_
9-27	2060-2064	cold	_
9-28	2065-2066	,	_
9-29	2067-2070	and	_
9-30	2071-2083	behaviorally	_
9-31	2084-2096	disinhibited	_
9-32	2097-2104	profile	_
9-33	2105-2106	.	_

10-1	2107-2110	Hum	_
10-2	2111-2116	Brain	_
10-3	2117-2121	Mapp	_
10-4	2122-2134	37:4017–4033	_
10-5	2135-2136	,	_
10-6	2137-2141	2016	_
10-7	2142-2143	.	_

11-1	2144-2145	©	_
11-2	2146-2150	2016	_
11-3	2151-2154	The	_
11-4	2155-2162	Authors	_
11-5	2163-2168	Human	_
11-6	2169-2174	Brain	_
11-7	2175-2182	Mapping	_
11-8	2183-2192	Published	_
11-9	2193-2195	by	_
11-10	2196-2201	Wiley	_
11-11	2202-2213	Periodicals	_
11-12	2214-2215	,	_
11-13	2216-2220	Inc.	_
11-14	2221-2230	MATERIALS	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
11-15	2231-2234	AND	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
11-16	2235-2242	METHODS	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
11-17	2243-2255	Participants	_
11-18	2256-2261	Fifty	_
11-19	2262-2270	severely	_
11-20	2271-2281	antisocial	http://maven.renci.org/NeuroBridge/neurobridge#PersonalityDisorder
11-21	2282-2286	male	_
11-22	2287-2295	juvenile	http://maven.renci.org/NeuroBridge/neurobridge#ConductDisorder
11-23	2296-2305	offenders	http://maven.renci.org/NeuroBridge/neurobridge#ConductDisorder
11-24	2306-2310	with	http://maven.renci.org/NeuroBridge/neurobridge#ConductDisorder
11-25	2311-2312	a	http://maven.renci.org/NeuroBridge/neurobridge#ConductDisorder
11-26	2313-2319	DSM‐IV	http://maven.renci.org/NeuroBridge/neurobridge#ConductDisorder
11-27	2320-2329	diagnosis	http://maven.renci.org/NeuroBridge/neurobridge#ConductDisorder
11-28	2330-2332	of	http://maven.renci.org/NeuroBridge/neurobridge#ConductDisorder
11-29	2333-2340	conduct	http://maven.renci.org/NeuroBridge/neurobridge#ConductDisorder
11-30	2341-2349	disorder	http://maven.renci.org/NeuroBridge/neurobridge#ConductDisorder
11-31	2350-2351	(	http://maven.renci.org/NeuroBridge/neurobridge#ConductDisorder
11-32	2352-2354	CD	http://maven.renci.org/NeuroBridge/neurobridge#ConductDisorder
11-33	2355-2356	)	http://maven.renci.org/NeuroBridge/neurobridge#ConductDisorder
11-34	2357-2358	(	_
11-35	2359-2363	mean	_
11-36	2364-2367	age	_
11-37	2368-2369	=	_
11-38	2370-2375	16.83	_
11-39	2376-2377	,	_
11-40	2378-2380	SD	_
11-41	2381-2382	=	_
11-42	2383-2387	1.32	_
11-43	2388-2389	)	_
11-44	2390-2394	were	_
11-45	2395-2403	included	_
11-46	2404-2406	in	_
11-47	2407-2410	the	_
11-48	2411-2418	present	_
11-49	2419-2424	study	_
11-50	2425-2426	.	_

12-1	2427-2430	All	_
12-2	2431-2443	participants	_
12-3	2444-2448	were	_
12-4	2449-2453	aged	_
12-5	2454-2456	15	_
12-6	2457-2459	to	_
12-7	2460-2462	19	_
12-8	2463-2468	years	_
12-9	2469-2472	old	_
12-10	2473-2476	and	_
12-11	2477-2481	were	_
12-12	2482-2498	medication‐naïve	_
12-13	2499-2500	.	_

13-1	2501-2509	Juvenile	http://maven.renci.org/NeuroBridge/neurobridge#AtypicalParkinsonism
13-2	2510-2519	offenders	http://maven.renci.org/NeuroBridge/neurobridge#AtypicalParkinsonism
13-3	2520-2524	with	http://maven.renci.org/NeuroBridge/neurobridge#AtypicalParkinsonism
13-4	2525-2527	CD	http://maven.renci.org/NeuroBridge/neurobridge#AtypicalParkinsonism
13-5	2528-2532	were	_
13-6	2533-2542	recruited	_
13-7	2543-2547	from	_
13-8	2548-2549	a	_
13-9	2550-2558	juvenile	_
13-10	2559-2568	detention	_
13-11	2569-2575	center	_
13-12	2576-2579	and	_
13-13	2580-2581	a	_
13-14	2582-2590	forensic	_
13-15	2591-2602	psychiatric	_
13-16	2603-2611	facility	_
13-17	2612-2613	,	_
13-18	2614-2617	and	_
13-19	2618-2621	had	_
13-20	2622-2625	all	_
13-21	2626-2630	been	_
13-22	2631-2640	convicted	_
13-23	2641-2644	for	_
13-24	2645-2651	crimes	_
13-25	2652-2656	such	_
13-26	2657-2659	as	_
13-27	2660-2667	assault	_
13-28	2668-2669	,	_
13-29	2670-2676	murder	_
13-30	2677-2678	,	_
13-31	2679-2682	and	_
13-32	2683-2688	armed	_
13-33	2689-2696	robbery	_
13-34	2697-2698	.	_

14-1	2699-2703	More	_
14-2	2704-2711	details	_
14-3	2712-2721	regarding	_
14-4	2722-2733	participant	_
14-5	2734-2743	inclusion	_
14-6	2744-2747	are	_
14-7	2748-2756	provided	_
14-8	2757-2759	in	_
14-9	2760-2763	the	_
14-10	2764-2774	Supporting	_
14-11	2775-2786	Information	_
14-12	2787-2788	.	_

15-1	2789-2797	Clinical	_
15-2	2798-2808	Assessment	_
15-3	2809-2812	For	_
15-4	2813-2816	all	_
15-5	2817-2825	juvenile	_
15-6	2826-2835	offenders	_
15-7	2836-2837	,	_
15-8	2838-2844	DSM‐IV	_
15-9	2845-2854	diagnoses	_
15-10	2855-2857	of	_
15-11	2858-2860	CD	_
15-12	2861-2865	were	_
15-13	2866-2875	confirmed	_
15-14	2876-2881	using	_
15-15	2882-2885	the	_
15-16	2886-2892	Kiddie	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceUseScale
15-17	2893-2901	Schedule	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceUseScale
15-18	2902-2905	for	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceUseScale
15-19	2906-2915	Affective	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceUseScale
15-20	2916-2925	Disorders	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceUseScale
15-21	2926-2929	and	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceUseScale
15-22	2930-2943	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceUseScale
15-23	2944-2945	(	_
15-24	2946-2955	K‐SADS‐PL	_
15-25	2956-2957	)	_
15-26	2958-2959	[	_
15-27	2960-2967	Kaufman	_
15-28	2968-2970	et	_
15-29	2971-2974	al.	_
15-30	2975-2976	,	_
15-31	2977-2981	1997	_
15-32	2982-2983	]	_
15-33	2984-2985	,	_
15-34	2986-2987	a	_
15-35	2988-2994	widely	_
15-36	2995-2999	used	_
15-37	3000-3015	semi‐structured	_
15-38	3016-3026	diagnostic	_
15-39	3027-3036	interview	_
15-40	3037-3038	.	_

16-1	3039-3042	All	_
16-2	3043-3051	juvenile	_
16-3	3052-3061	offenders	_
16-4	3062-3065	had	_
16-5	3066-3068	to	_
16-6	3069-3076	fulfill	_
16-7	3077-3085	criteria	_
16-8	3086-3089	for	_
16-9	3090-3092	CD	_
16-10	3093-3097	with	_
16-11	3098-3100	at	_
16-12	3101-3106	least	_
16-13	3107-3110	one	_
16-14	3111-3121	aggressive	_
16-15	3122-3129	symptom	_
16-16	3130-3131	(	_
16-17	3132-3136	e.g.	_
16-18	3137-3138	,	_
16-19	3139-3143	used	_
16-20	3144-3145	a	_
16-21	3146-3152	weapon	_
16-22	3153-3154	,	_
16-23	3155-3158	has	_
16-24	3159-3163	been	_
16-25	3164-3174	physically	_
16-26	3175-3180	cruel	_
16-27	3181-3183	to	_
16-28	3184-3190	people	_
16-29	3191-3192	,	_
16-30	3193-3196	has	_
16-31	3197-3203	stolen	_
16-32	3204-3209	while	_
16-33	3210-3221	confronting	_
16-34	3222-3223	a	_
16-35	3224-3230	victim	_
16-36	3231-3232	)	_
16-37	3233-3234	.	_

17-1	3235-3244	Consonant	_
17-2	3245-3249	with	_
17-3	3250-3256	recent	_
17-4	3257-3272	neurobiological	_
17-5	3273-3277	work	_
17-6	3278-3280	on	_
17-7	3281-3289	juvenile	_
17-8	3290-3301	psychopathy	_
17-9	3302-3303	[	_
17-10	3304-3308	Cohn	_
17-11	3309-3311	et	_
17-12	3312-3315	al.	_
17-13	3316-3317	,	_
17-14	3318-3322	2014	_
17-15	3323-3324	,	_
17-16	3325-3329	2015	_
17-17	3330-3331	;	_
17-18	3332-3341	Fairchild	_
17-19	3342-3344	et	_
17-20	3345-3348	al.	_
17-21	3349-3350	,	_
17-22	3351-3355	2013	_
17-23	3356-3357	;	_
17-24	3358-3363	Marsh	_
17-25	3364-3366	et	_
17-26	3367-3370	al.	_
17-27	3371-3372	,	_
17-28	3373-3377	2008	_
17-29	3378-3379	;	_
17-30	3380-3384	Pape	_
17-31	3385-3387	et	_
17-32	3388-3391	al.	_
17-33	3392-3393	,	_
17-34	3394-3398	2015	_
17-35	3399-3400	]	_
17-36	3401-3402	,	_
17-37	3403-3406	the	_
17-38	3407-3412	Youth	http://maven.renci.org/NeuroBridge/neurobridge#PsychopathologyScale
17-39	3413-3425	Psychopathic	http://maven.renci.org/NeuroBridge/neurobridge#PsychopathologyScale
17-40	3426-3432	Traits	http://maven.renci.org/NeuroBridge/neurobridge#PsychopathologyScale
17-41	3433-3442	Inventory	http://maven.renci.org/NeuroBridge/neurobridge#PsychopathologyScale
17-42	3443-3444	(	http://maven.renci.org/NeuroBridge/neurobridge#PsychopathologyScale
17-43	3445-3448	YPI	http://maven.renci.org/NeuroBridge/neurobridge#PsychopathologyScale
17-44	3449-3450	)	_
17-45	3451-3452	[	_
17-46	3453-3462	Andershed	_
17-47	3463-3465	et	_
17-48	3466-3469	al.	_
17-49	3470-3471	,	_
17-50	3472-3476	2002	_
17-51	3477-3478	]	_
17-52	3479-3482	was	_
17-53	3483-3487	used	_
17-54	3488-3490	to	_
17-55	3491-3497	assess	_
17-56	3498-3510	psychopathic	_
17-57	3511-3517	traits	_
17-58	3518-3520	in	_
17-59	3521-3539	conduct‐disordered	_
17-60	3540-3548	juvenile	_
17-61	3549-3558	offenders	_
17-62	3559-3560	.	_

18-1	3561-3564	The	_
18-2	3565-3568	YPI	_
18-3	3569-3571	is	_
18-4	3572-3573	a	_
18-5	3574-3580	widely	_
18-6	3581-3585	used	_
18-7	3586-3596	instrument	_
18-8	3597-3605	composed	_
18-9	3606-3608	of	_
18-10	3609-3611	50	_
18-11	3612-3623	self‐report	_
18-12	3624-3629	items	_
18-13	3630-3634	that	_
18-14	3635-3641	assess	_
18-15	3642-3647	adult	_
18-16	3648-3664	psychopathy‐like	_
18-17	3665-3676	personality	_
18-18	3677-3683	traits	_
18-19	3684-3686	in	_
18-20	3687-3696	juveniles	_
18-21	3697-3698	,	_
18-22	3699-3703	with	_
18-23	3704-3712	adequate	_
18-24	3713-3721	validity	_
18-25	3722-3725	and	_
18-26	3726-3737	reliability	_
18-27	3738-3739	[	_
18-28	3740-3747	Neumann	_
18-29	3748-3751	and	_
18-30	3752-3759	Pardini	_
18-31	3760-3761	,	_
18-32	3762-3766	2014	_
18-33	3767-3768	;	_
18-34	3769-3774	Pihet	_
18-35	3775-3777	et	_
18-36	3778-3781	al.	_
18-37	3782-3783	,	_
18-38	3784-3788	2014	_
18-39	3789-3790	;	_
18-40	3791-3800	Poythress	_
18-41	3801-3803	et	_
18-42	3804-3807	al.	_
18-43	3808-3809	,	_
18-44	3810-3814	2006	_
18-45	3815-3816	]	_
18-46	3817-3818	.	_

19-1	3819-3822	Its	_
19-2	3823-3828	items	_
19-3	3829-3841	collectively	_
19-4	3842-3847	probe	_
19-5	3848-3851	the	_
19-6	3852-3858	widely	_
19-7	3859-3867	accepted	_
19-8	3868-3876	3‐factor	_
19-9	3877-3882	model	_
19-10	3883-3885	of	_
19-11	3886-3897	psychopathy	_
19-12	3898-3899	,	_
19-13	3900-3905	which	_
19-14	3906-3913	asserts	_
19-15	3914-3924	deviations	_
19-16	3925-3927	in	_
19-17	3928-3937	affective	_
19-18	3938-3939	,	_
19-19	3940-3953	interpersonal	_
19-20	3954-3955	,	_
19-21	3956-3959	and	_
19-22	3960-3970	behavioral	_
19-23	3971-3982	personality	_
19-24	3983-3990	domains	_
19-25	3991-3992	(	_
19-26	3993-3997	i.e.	_
19-27	3998-3999	,	_
19-28	4000-4005	trait	_
19-29	4006-4016	dimensions	_
19-30	4017-4018	)	_
19-31	4019-4020	[	_
19-32	4021-4030	Andershed	_
19-33	4031-4033	et	_
19-34	4034-4037	al.	_
19-35	4038-4039	,	_
19-36	4040-4044	2007	_
19-37	4045-4046	;	_
19-38	4047-4052	Cooke	_
19-39	4053-4056	and	_
19-40	4057-4063	Michie	_
19-41	4064-4065	,	_
19-42	4066-4070	2001	_
19-43	4071-4072	;	_
19-44	4073-4078	Jones	_
19-45	4079-4081	et	_
19-46	4082-4085	al.	_
19-47	4086-4087	,	_
19-48	4088-4092	2006	_
19-49	4093-4094	;	_
19-50	4095-4102	Neumann	_
19-51	4103-4105	et	_
19-52	4106-4109	al.	_
19-53	4110-4111	,	_
19-54	4112-4116	2006	_
19-55	4117-4118	;	_
19-56	4119-4124	Perez	_
19-57	4125-4127	et	_
19-58	4128-4131	al.	_
19-59	4132-4133	,	_
19-60	4134-4138	2015	_
19-61	4139-4140	;	_
19-62	4141-4146	Skeem	_
19-63	4147-4149	et	_
19-64	4150-4153	al.	_
19-65	4154-4155	,	_
19-66	4156-4160	2003	_
19-67	4161-4162	]	_
19-68	4163-4164	.	_

20-1	4165-4168	Its	_
20-2	4169-4178	affective	_
20-3	4179-4188	dimension	_
20-4	4189-4198	comprises	_
20-5	4199-4210	callousness	_
20-6	4211-4212	,	_
20-7	4213-4227	unemotionality	_
20-8	4228-4229	,	_
20-9	4230-4233	and	_
20-10	4234-4249	remorselessness	_
20-11	4250-4251	;	_
20-12	4252-4255	its	_
20-13	4256-4269	interpersonal	_
20-14	4270-4279	dimension	_
20-15	4280-4288	includes	_
20-16	4289-4298	dishonest	_
20-17	4299-4304	charm	_
20-18	4305-4306	,	_
20-19	4307-4317	egocentric	_
20-20	4318-4329	grandiosity	_
20-21	4330-4331	,	_
20-22	4332-4337	lying	_
20-23	4338-4339	,	_
20-24	4340-4343	and	_
20-25	4344-4356	manipulation	_
20-26	4357-4358	;	_
20-27	4359-4364	while	_
20-28	4365-4368	its	_
20-29	4369-4379	behavioral	_
20-30	4380-4389	dimension	_
20-31	4390-4398	features	_
20-32	4399-4412	impulsiveness	_
20-33	4413-4414	,	_
20-34	4415-4421	thrill	_
20-35	4422-4429	seeking	_
20-36	4430-4431	,	_
20-37	4432-4435	and	_
20-38	4436-4452	irresponsibility	_
20-39	4453-4454	.	_

21-1	4455-4457	In	_
21-2	4458-4462	line	_
21-3	4463-4467	with	_
21-4	4468-4476	previous	_
21-5	4477-4481	work	_
21-6	4482-4483	[	_
21-7	4484-4493	Andershed	_
21-8	4494-4496	et	_
21-9	4497-4500	al.	_
21-10	4501-4502	,	_
21-11	4503-4507	2007	_
21-12	4508-4509	;	_
21-13	4510-4514	Cohn	_
21-14	4515-4517	et	_
21-15	4518-4521	al.	_
21-16	4522-4523	,	_
21-17	4524-4528	2014	_
21-18	4529-4530	,	_
21-19	4531-4535	2015	_
21-20	4536-4537	]	_
21-21	4538-4539	,	_
21-22	4540-4543	the	_
21-23	4544-4549	three	_
21-24	4550-4555	trait	_
21-25	4556-4566	dimensions	_
21-26	4567-4571	were	_
21-27	4572-4582	correlated	_
21-28	4583-4585	in	_
21-29	4586-4589	the	_
21-30	4590-4597	current	_
21-31	4598-4603	study	_
21-32	4604-4605	(	_
21-33	4606-4607	r	_
21-34	4608-4609	=	_
21-35	4610-4619	0.61‐0.75	_
21-36	4620-4621	;	_
21-37	4622-4625	all	_
21-38	4626-4627	P	_
21-39	4628-4629	<	_
21-40	4630-4634	0.01	_
21-41	4635-4636	)	_
21-42	4637-4638	.	_

22-1	4639-4649	Additional	_
22-2	4650-4658	measures	_
22-3	4659-4663	were	_
22-4	4664-4668	also	_
22-5	4669-4673	used	_
22-6	4674-4676	to	_
22-7	4677-4684	further	_
22-8	4685-4691	assess	_
22-9	4692-4695	the	_
22-10	4696-4704	severity	_
22-11	4705-4707	of	_
22-12	4708-4718	antisocial	_
22-13	4719-4729	tendencies	_
22-14	4730-4731	,	_
22-15	4732-4734	as	_
22-16	4735-4739	well	_
22-17	4740-4742	as	_
22-18	4743-4756	externalizing	_
22-19	4757-4760	and	_
22-20	4761-4774	internalizing	_
22-21	4775-4789	symptomatology	_
22-22	4790-4791	.	_

23-1	4792-4797	These	_
23-2	4798-4806	included	_
23-3	4807-4810	the	_
23-4	4811-4816	Youth	http://maven.renci.org/NeuroBridge/neurobridge#ReportedMeasurement
23-5	4817-4828	Self‐Report	http://maven.renci.org/NeuroBridge/neurobridge#ReportedMeasurement
23-6	4829-4830	(	http://maven.renci.org/NeuroBridge/neurobridge#ReportedMeasurement
23-7	4831-4834	YSR	http://maven.renci.org/NeuroBridge/neurobridge#ReportedMeasurement
23-8	4835-4836	)	http://maven.renci.org/NeuroBridge/neurobridge#ReportedMeasurement
23-9	4837-4838	[	_
23-10	4839-4848	Achenbach	_
23-11	4849-4850	,	_
23-12	4851-4855	1991	_
23-13	4856-4857	]	_
23-14	4858-4859	,	_
23-15	4860-4865	Basic	http://maven.renci.org/NeuroBridge/neurobridge#PsychopathologyScale
23-16	4866-4873	Empathy	http://maven.renci.org/NeuroBridge/neurobridge#PsychopathologyScale
23-17	4874-4879	Scale	http://maven.renci.org/NeuroBridge/neurobridge#PsychopathologyScale
23-18	4880-4881	(	http://maven.renci.org/NeuroBridge/neurobridge#PsychopathologyScale
23-19	4882-4885	BES	http://maven.renci.org/NeuroBridge/neurobridge#PsychopathologyScale
23-20	4886-4887	)	http://maven.renci.org/NeuroBridge/neurobridge#PsychopathologyScale
23-21	4888-4889	[	_
23-22	4890-4898	Jolliffe	_
23-23	4899-4902	and	_
23-24	4903-4913	Farrington	_
23-25	4914-4915	,	_
23-26	4916-4920	2006	_
23-27	4921-4922	]	_
23-28	4923-4924	,	_
23-29	4925-4928	and	_
23-30	4929-4947	Reactive‐Proactive	http://maven.renci.org/NeuroBridge/neurobridge#CReactiveProtein
23-31	4948-4958	Aggression	http://maven.renci.org/NeuroBridge/neurobridge#CReactiveProtein
23-32	4959-4972	Questionnaire	http://maven.renci.org/NeuroBridge/neurobridge#CReactiveProtein
23-33	4973-4974	(	_
23-34	4975-4978	RPQ	_
23-35	4979-4980	)	_
23-36	4981-4982	[	_
23-37	4983-4988	Raine	_
23-38	4989-4991	et	_
23-39	4992-4995	al.	_
23-40	4996-4997	,	_
23-41	4998-5002	2006	_
23-42	5003-5004	]	_
23-43	5005-5006	.	_

24-1	5007-5011	More	_
24-2	5012-5020	detailed	_
24-3	5021-5032	description	_
24-4	5033-5035	of	_
24-5	5036-5041	these	_
24-6	5042-5050	measures	_
24-7	5051-5053	is	_
24-8	5054-5062	provided	_
24-9	5063-5065	in	_
24-10	5066-5069	the	_
24-11	5070-5080	Supporting	_
24-12	5081-5092	Information	_
24-13	5093-5094	.	_

25-1	5095-5099	Data	_
25-2	5100-5111	Acquisition	_
25-3	5112-5115	and	_
25-4	5116-5129	Preprocessing	_
25-5	5130-5143	Resting‐state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
25-6	5144-5145	(	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
25-7	5146-5148	RS	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
25-8	5149-5150	)	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
25-9	5151-5155	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
25-10	5156-5160	data	_
25-11	5161-5165	were	_
25-12	5166-5175	collected	_
25-13	5176-5181	using	_
25-14	5182-5183	a	_
25-15	5184-5191	Philips	_
25-16	5192-5194	3T	_
25-17	5195-5202	Achieva	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
25-18	5203-5206	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
25-19	5207-5214	scanner	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
25-20	5215-5216	(	_
25-21	5217-5224	Philips	_
25-22	5225-5235	Healthcare	_
25-23	5236-5237	,	_
25-24	5238-5242	Best	_
25-25	5243-5244	,	_
25-26	5245-5248	The	_
25-27	5249-5260	Netherlands	_
25-28	5261-5262	)	_
25-29	5263-5267	with	_
25-30	5268-5269	a	_
25-31	5270-5280	32‐channel	_
25-32	5281-5286	SENSE	_
25-33	5287-5288	(	_
25-34	5289-5300	Sensitivity	_
25-35	5301-5309	Encoding	_
25-36	5310-5311	)	_
25-37	5312-5316	head	_
25-38	5317-5321	coil	_
25-39	5322-5323	.	_

26-1	5324-5329	Prior	_
26-2	5330-5332	to	_
26-3	5333-5341	scanning	_
26-4	5342-5343	,	_
26-5	5344-5347	all	_
26-6	5348-5360	participants	_
26-7	5361-5365	were	_
26-8	5366-5376	accustomed	_
26-9	5377-5379	to	_
26-10	5380-5383	the	_
26-11	5384-5392	scanning	_
26-12	5393-5402	situation	_
26-13	5403-5405	by	_
26-14	5406-5411	lying	_
26-15	5412-5414	in	_
26-16	5415-5416	a	_
26-17	5417-5422	dummy	_
26-18	5423-5430	scanner	_
26-19	5431-5434	and	_
26-20	5435-5442	hearing	_
26-21	5443-5450	scanner	_
26-22	5451-5457	sounds	_
26-23	5458-5459	.	_

27-1	5460-5466	During	_
27-2	5467-5470	the	_
27-3	5471-5481	7.5‐minute	_
27-4	5482-5484	RS	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
27-5	5485-5489	scan	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
27-6	5490-5491	,	_
27-7	5492-5504	participants	_
27-8	5505-5509	were	_
27-9	5510-5520	instructed	_
27-10	5521-5523	to	_
27-11	5524-5527	lie	_
27-12	5528-5533	still	_
27-13	5534-5538	with	_
27-14	5539-5544	their	_
27-15	5545-5549	eyes	_
27-16	5550-5554	open	_
27-17	5555-5560	while	_
27-18	5561-5569	fixating	_
27-19	5570-5572	on	_
27-20	5573-5574	a	_
27-21	5575-5580	white	_
27-22	5581-5591	cross‐hair	_
27-23	5592-5599	against	_
27-24	5600-5601	a	_
27-25	5602-5607	black	_
27-26	5608-5618	background	_
27-27	5619-5620	.	_

28-1	5621-5625	Head	_
28-2	5626-5632	motion	_
28-3	5633-5636	was	_
28-4	5637-5644	limited	_
28-5	5645-5650	using	_
28-6	5651-5658	padding	_
28-7	5659-5662	and	_
28-8	5663-5672	restraint	_
28-9	5673-5674	.	_

29-1	5675-5676	A	_
29-2	5677-5682	total	_
29-3	5683-5685	of	_
29-4	5686-5689	200	_
29-5	5690-5692	T2	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
29-6	5693-5694	*	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
29-7	5695-5704	‐weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
29-8	5705-5718	gradient‐echo	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
29-9	5719-5730	echo‐planar	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
29-10	5731-5738	imaging	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
29-11	5739-5740	(	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
29-12	5741-5744	EPI	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
29-13	5745-5746	)	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
29-14	5747-5754	volumes	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
29-15	5755-5759	were	_
29-16	5760-5768	acquired	_
29-17	5769-5770	,	_
29-18	5771-5776	using	_
29-19	5777-5780	the	_
29-20	5781-5790	following	_
29-21	5791-5795	scan	_
29-22	5796-5806	parameters	_
29-23	5807-5808	:	_
29-24	5809-5819	repetition	_
29-25	5820-5824	time	_
29-26	5825-5826	(	_
29-27	5827-5829	TR	_
29-28	5830-5831	)	_
29-29	5832-5833	=	_
29-30	5834-5838	2200	_
29-31	5839-5841	ms	_
29-32	5842-5843	,	_
29-33	5844-5848	echo	_
29-34	5849-5853	time	_
29-35	5854-5855	(	_
29-36	5856-5858	TE	_
29-37	5859-5860	)	_
29-38	5861-5862	=	_
29-39	5863-5865	30	_
29-40	5866-5868	ms	_
29-41	5869-5870	,	_
29-42	5871-5875	flip	_
29-43	5876-5881	angle	_
29-44	5882-5883	=	_
29-45	5884-5887	80°	_
29-46	5888-5889	,	_
29-47	5890-5892	38	_
29-48	5893-5903	transverse	_
29-49	5904-5910	slices	_
29-50	5911-5915	with	_
29-51	5916-5918	an	_
29-52	5919-5927	in‐plane	_
29-53	5928-5933	voxel	_
29-54	5934-5944	resolution	_
29-55	5945-5947	of	_
29-56	5948-5957	2.75x2.75	_
29-57	5958-5960	mm	_
29-58	5961-5962	,	_
29-59	5963-5967	2.75	_
29-60	5968-5970	mm	_
29-61	5971-5976	slice	_
29-62	5977-5986	thickness	_
29-63	5987-5988	,	_
29-64	5989-5994	field	_
29-65	5995-5997	of	_
29-66	5998-6002	view	_
29-67	6003-6004	(	_
29-68	6005-6008	FOV	_
29-69	6009-6010	)	_
29-70	6011-6012	=	_
29-71	6013-6020	220x220	_
29-72	6021-6023	mm	_
29-73	6024-6025	.	_

30-1	6026-6029	For	_
30-2	6030-6040	anatomical	_
30-3	6041-6050	reference	_
30-4	6051-6052	,	_
30-5	6053-6054	a	_
30-6	6055-6066	T1‐weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
30-7	6067-6077	anatomical	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
30-8	6078-6082	scan	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
30-9	6083-6086	was	_
30-10	6087-6095	acquired	_
30-11	6096-6099	for	_
30-12	6100-6104	each	_
30-13	6105-6116	participant	_
30-14	6117-6121	with	_
30-15	6122-6125	the	_
30-16	6126-6135	following	_
30-17	6136-6140	scan	_
30-18	6141-6151	parameters	_
30-19	6152-6153	:	_
30-20	6154-6156	TR	_
30-21	6157-6158	=	_
30-22	6159-6162	9.8	_
30-23	6163-6165	ms	_
30-24	6166-6167	,	_
30-25	6168-6170	TE	_
30-26	6171-6172	=	_
30-27	6173-6176	4.6	_
30-28	6177-6179	ms	_
30-29	6180-6181	,	_
30-30	6182-6185	140	_
30-31	6186-6194	sagittal	_
30-32	6195-6201	slices	_
30-33	6202-6206	with	_
30-34	6207-6209	an	_
30-35	6210-6219	isotropic	_
30-36	6220-6225	voxel	_
30-37	6226-6236	resolution	_
30-38	6237-6239	of	_
30-39	6240-6253	0.88x0.87x1.2	_
30-40	6254-6256	mm	_
30-41	6257-6258	,	_
30-42	6259-6262	and	_
30-43	6263-6266	FOV	_
30-44	6267-6268	=	_
30-45	6269-6276	224x177	_
30-46	6277-6279	mm	_
30-47	6280-6281	.	_

31-1	6282-6285	All	_
31-2	6286-6290	data	_
31-3	6291-6295	were	_
31-4	6296-6308	preprocessed	_
31-5	6309-6312	and	_
31-6	6313-6321	analyzed	_
31-7	6322-6327	using	_
31-8	6328-6331	FSL	_
31-9	6332-6339	version	_
31-10	6340-6345	5.0.7	_
31-11	6346-6347	(	_
31-12	6348-6352	http	_
31-13	6353-6354	:	_
31-14	6355-6388	//fsl.fmrib.ox.ac.uk/fsl/fslwiki/	_
31-15	6389-6390	)	_
31-16	6391-6392	.	_

32-1	6393-6406	Preprocessing	_
32-2	6407-6416	consisted	_
32-3	6417-6419	of	_
32-4	6420-6435	nonbrain‐tissue	_
32-5	6436-6443	removal	_
32-6	6444-6445	,	_
32-7	6446-6452	motion	_
32-8	6453-6463	correction	_
32-9	6464-6465	,	_
32-10	6466-6471	grand	_
32-11	6472-6482	mean‐based	_
32-12	6483-6492	intensity	_
32-13	6493-6506	normalization	_
32-14	6507-6509	of	_
32-15	6510-6513	the	_
32-16	6514-6520	entire	_
32-17	6521-6524	4‐D	_
32-18	6525-6529	data	_
32-19	6530-6533	set	_
32-20	6534-6536	by	_
32-21	6537-6538	a	_
32-22	6539-6545	single	_
32-23	6546-6553	scaling	_
32-24	6554-6560	factor	_
32-25	6561-6562	,	_
32-26	6563-6568	slice	_
32-27	6569-6575	timing	_
32-28	6576-6586	correction	_
32-29	6587-6588	,	_
32-30	6589-6596	spatial	_
32-31	6597-6606	smoothing	_
32-32	6607-6611	with	_
32-33	6612-6613	a	_
32-34	6614-6615	6	_
32-35	6616-6618	mm	_
32-36	6619-6623	full	_
32-37	6624-6629	width	_
32-38	6630-6632	at	_
32-39	6633-6637	half	_
32-40	6638-6645	maximum	_
32-41	6646-6654	Gaussian	_
32-42	6655-6661	kernel	_
32-43	6662-6663	,	_
32-44	6664-6667	and	_
32-45	6668-6676	temporal	_
32-46	6677-6685	bandpass	_
32-47	6686-6695	filtering	_
32-48	6696-6698	at	_
32-49	6699-6704	0.009	_
32-50	6705-6706	<	_
32-51	6707-6708	f	_
32-52	6709-6710	<	_
32-53	6711-6715	0.15	_
32-54	6716-6718	Hz	_
32-55	6719-6720	,	_
32-56	6721-6726	which	_
32-57	6727-6735	improves	_
32-58	6736-6740	BOLD	_
32-59	6741-6747	signal	_
32-60	6748-6758	estimation	_
32-61	6759-6762	and	_
32-62	6763-6771	produces	_
32-63	6772-6784	connectivity	_
32-64	6785-6793	patterns	_
32-65	6794-6798	that	_
32-66	6799-6805	relate	_
32-67	6806-6810	most	_
32-68	6811-6818	closely	_
32-69	6819-6821	to	_
32-70	6822-6832	task‐based	_
32-71	6833-6844	activations	_
32-72	6845-6846	[	_
32-73	6847-6855	Aghajani	_
32-74	6856-6858	et	_
32-75	6859-6862	al.	_
32-76	6863-6864	,	_
32-77	6865-6869	2016	_
32-78	6870-6871	;	_
32-79	6872-6875	Fox	_
32-80	6876-6879	and	_
32-81	6880-6887	Raichle	_
32-82	6888-6889	,	_
32-83	6890-6894	2007	_
32-84	6895-6896	;	_
32-85	6897-6905	Fransson	_
32-86	6906-6907	,	_
32-87	6908-6912	2006	_
32-88	6913-6914	;	_
32-89	6915-6918	Roy	_
32-90	6919-6921	et	_
32-91	6922-6925	al.	_
32-92	6926-6927	,	_
32-93	6928-6932	2009	_
32-94	6933-6934	;	_
32-95	6935-6939	Toro	_
32-96	6940-6942	et	_
32-97	6943-6946	al.	_
32-98	6947-6948	,	_
32-99	6949-6953	2008	_
32-100	6954-6955	]	_
32-101	6956-6957	.	_

33-1	6958-6965	Finally	_
33-2	6966-6967	,	_
33-3	6968-6971	the	_
33-4	6972-6974	RS	_
33-5	6975-6979	data	_
33-6	6980-6984	were	_
33-7	6985-6995	registered	_
33-8	6996-6998	to	_
33-9	6999-7010	T1‐weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
33-10	7011-7021	anatomical	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
33-11	7022-7028	images	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
33-12	7029-7030	,	_
33-13	7031-7034	and	_
33-14	7035-7047	subsequently	_
33-15	7048-7050	to	_
33-16	7051-7054	the	_
33-17	7055-7059	2‐mm	_
33-18	7060-7068	Montreal	_
33-19	7069-7081	Neurological	_
33-20	7082-7091	Institute	_
33-21	7092-7093	(	_
33-22	7094-7097	MNI	_
33-23	7098-7099	)	_
33-24	7100-7108	standard	_
33-25	7109-7114	space	_
33-26	7115-7120	image	_
33-27	7121-7122	[	_
33-28	7123-7131	Aghajani	_
33-29	7132-7134	et	_
33-30	7135-7138	al.	_
33-31	7139-7140	,	_
33-32	7141-7145	2016	_
33-33	7146-7147	;	_
33-34	7148-7156	Aghajani	_
33-35	7157-7159	et	_
33-36	7160-7163	al.	_
33-37	7164-7165	,	_
33-38	7166-7170	2016	_
33-39	7171-7172	;	_
33-40	7173-7176	Roy	_
33-41	7177-7179	et	_
33-42	7180-7183	al.	_
33-43	7184-7185	,	_
33-44	7186-7190	2013	_
33-45	7191-7192	]	_
33-46	7193-7194	.	_

34-1	7195-7198	The	_
34-2	7199-7206	maximum	_
34-3	7207-7216	allowable	_
34-4	7217-7221	mean	_
34-5	7222-7234	displacement	_
34-6	7235-7238	due	_
34-7	7239-7241	to	_
34-8	7242-7251	excessive	_
34-9	7252-7256	head	_
34-10	7257-7263	motion	_
34-11	7264-7267	was	_
34-12	7268-7271	set	_
34-13	7272-7274	at	_
34-14	7275-7276	3	_
34-15	7277-7279	mm	_
34-16	7280-7291	translation	_
34-17	7292-7294	or	_
34-18	7295-7297	3º	_
34-19	7298-7306	rotation	_
34-20	7307-7309	in	_
34-21	7310-7313	any	_
34-22	7314-7323	direction	_
34-23	7324-7325	.	_

35-1	7326-7338	Additionally	_
35-2	7339-7340	,	_
35-3	7341-7343	to	_
35-4	7344-7349	guard	_
35-5	7350-7357	against	_
35-6	7358-7361	the	_
35-7	7362-7369	effects	_
35-8	7370-7372	of	_
35-9	7373-7383	in‐scanner	_
35-10	7384-7396	micro‐motion	_
35-11	7397-7399	on	_
35-12	7400-7412	connectivity	_
35-13	7413-7421	patterns	_
35-14	7422-7424	we	_
35-15	7425-7436	implemented	_
35-16	7437-7453	motion‐censoring	_
35-17	7454-7455	,	_
35-18	7456-7460	also	_
35-19	7461-7466	known	_
35-20	7467-7469	as	_
35-21	7470-7471	“	_
35-22	7472-7481	scrubbing	_
35-23	7482-7483	”	_
35-24	7484-7485	[	_
35-25	7486-7491	Power	_
35-26	7492-7494	et	_
35-27	7495-7498	al.	_
35-28	7499-7500	,	_
35-29	7501-7505	2012	_
35-30	7506-7507	;	_
35-31	7508-7521	Satterthwaite	_
35-32	7522-7524	et	_
35-33	7525-7528	al.	_
35-34	7529-7530	,	_
35-35	7531-7535	2013	_
35-36	7536-7537	]	_
35-37	7538-7539	(	_
35-38	7540-7543	see	_
35-39	7544-7554	Supporting	_
35-40	7555-7566	Information	_
35-41	7567-7570	for	_
35-42	7571-7578	details	_
35-43	7579-7580	)	_
35-44	7581-7582	.	_

36-1	7583-7593	Functional	_
36-2	7594-7606	Connectivity	_
36-3	7607-7615	Analysis	_
36-4	7616-7621	Given	_
36-5	7622-7630	apparent	_
36-6	7631-7645	lateralization	_
36-7	7646-7653	effects	_
36-8	7654-7656	in	_
36-9	7657-7666	amygdalar	_
36-10	7667-7680	functionality	_
36-11	7681-7684	and	_
36-12	7685-7696	subregional	_
36-13	7697-7709	connectivity	_
36-14	7710-7711	[	_
36-15	7712-7720	Aghajani	_
36-16	7721-7723	et	_
36-17	7724-7726	al	_
36-18	7727-7728	.	_

37-1	7729-7733	2016	_
37-2	7734-7735	,	_
37-3	7736-7740	2016	_
37-4	7741-7742	;	_
37-5	7743-7747	Baas	_
37-6	7748-7750	et	_
37-7	7751-7754	al.	_
37-8	7755-7756	,	_
37-9	7757-7761	2004	_
37-10	7762-7763	;	_
37-11	7764-7769	Brown	_
37-12	7770-7772	et	_
37-13	7773-7776	al.	_
37-14	7777-7778	,	_
37-15	7779-7783	2014	_
37-16	7784-7785	;	_
37-17	7786-7799	Gabard‐Durnam	_
37-18	7800-7802	et	_
37-19	7803-7806	al.	_
37-20	7807-7808	,	_
37-21	7809-7813	2014	_
37-22	7814-7815	;	_
37-23	7816-7819	Qin	_
37-24	7820-7822	et	_
37-25	7823-7826	al.	_
37-26	7827-7828	,	_
37-27	7829-7833	2014	_
37-28	7834-7835	;	_
37-29	7836-7844	Sergerie	_
37-30	7845-7847	et	_
37-31	7848-7851	al.	_
37-32	7852-7853	,	_
37-33	7854-7858	2008	_
37-34	7859-7860	;	_
37-35	7861-7870	Styliadis	_
37-36	7871-7873	et	_
37-37	7874-7877	al.	_
37-38	7878-7879	,	_
37-39	7880-7884	2014	_
37-40	7885-7886	]	_
37-41	7887-7888	,	_
37-42	7889-7892	and	_
37-43	7893-7895	in	_
37-44	7896-7900	line	_
37-45	7901-7905	with	_
37-46	7906-7912	recent	_
37-47	7913-7917	work	_
37-48	7918-7919	[	_
37-49	7920-7928	Aghajani	_
37-50	7929-7931	et	_
37-51	7932-7935	al.	_
37-52	7936-7937	,	_
37-53	7938-7942	2016	_
37-54	7943-7944	;	_
37-55	7945-7948	Qin	_
37-56	7949-7951	et	_
37-57	7952-7955	al.	_
37-58	7956-7957	,	_
37-59	7958-7962	2012	_
37-60	7963-7964	,	_
37-61	7965-7969	2014	_
37-62	7970-7971	]	_
37-63	7972-7973	,	_
37-64	7974-7977	BLA	_
37-65	7978-7981	and	_
37-66	7982-7985	CMA	_
37-67	7986-7992	region	_
37-68	7993-7995	of	_
37-69	7996-8004	interest	_
37-70	8005-8006	(	_
37-71	8007-8010	ROI	_
37-72	8011-8012	)	_
37-73	8013-8018	masks	_
37-74	8019-8023	were	_
37-75	8024-8031	created	_
37-76	8032-8034	in	_
37-77	8035-8039	each	_
37-78	8040-8050	hemisphere	_
37-79	8051-8052	(	_
37-80	8053-8056	see	_
37-81	8057-8067	Supporting	_
37-82	8068-8079	Information	_
37-83	8080-8081	)	_
37-84	8082-8083	,	_
37-85	8084-8087	and	_
37-86	8088-8092	used	_
37-87	8093-8095	to	_
37-88	8096-8103	extract	_
37-89	8104-8114	individual	_
37-90	8115-8126	participant	_
37-91	8127-8129	's	_
37-92	8130-8134	mean	_
37-93	8135-8139	time	_
37-94	8140-8146	series	_
37-95	8147-8153	within	_
37-96	8154-8157	BLA	_
37-97	8158-8161	and	_
37-98	8162-8165	CMA	_
37-99	8166-8175	complexes	_
37-100	8176-8177	.	_

38-1	8178-8188	Seed‐based	_
38-2	8189-8200	whole‐brain	_
38-3	8201-8204	iFC	_
38-4	8205-8213	analysis	_
38-5	8214-8225	implemented	_
38-6	8226-8232	within	_
38-7	8233-8236	FSL	_
38-8	8237-8241	FEAT	_
38-9	8242-8243	[	_
38-10	8244-8253	Jenkinson	_
38-11	8254-8256	et	_
38-12	8257-8260	al.	_
38-13	8261-8262	,	_
38-14	8263-8267	2012	_
38-15	8268-8269	]	_
38-16	8270-8271	,	_
38-17	8272-8275	was	_
38-18	8276-8280	then	_
38-19	8281-8289	employed	_
38-20	8290-8292	to	_
38-21	8293-8299	reveal	_
38-22	8300-8303	BLA	_
38-23	8304-8307	and	_
38-24	8308-8311	CMA	_
38-25	8312-8324	connectivity	_
38-26	8325-8333	patterns	_
38-27	8334-8335	[	_
38-28	8336-8339	Fox	_
38-29	8340-8343	and	_
38-30	8344-8351	Raichle	_
38-31	8352-8353	,	_
38-32	8354-8358	2007	_
38-33	8359-8360	]	_
38-34	8361-8362	.	_

39-1	8363-8375	Specifically	_
39-2	8376-8377	,	_
39-3	8378-8381	for	_
39-4	8382-8386	each	_
39-5	8387-8398	participant	_
39-6	8399-8400	,	_
39-7	8401-8404	and	_
39-8	8405-8407	in	_
39-9	8408-8412	each	_
39-10	8413-8423	hemisphere	_
39-11	8424-8425	,	_
39-12	8426-8427	a	_
39-13	8428-8435	general	_
39-14	8436-8442	linear	_
39-15	8443-8448	model	_
39-16	8449-8450	(	_
39-17	8451-8454	GLM	_
39-18	8455-8456	)	_
39-19	8457-8460	was	_
39-20	8461-8468	created	_
39-21	8469-8473	that	_
39-22	8474-8482	included	_
39-23	8483-8493	individual	_
39-24	8494-8505	participant	_
39-25	8506-8508	's	_
39-26	8509-8513	mean	_
39-27	8514-8518	time	_
39-28	8519-8525	series	_
39-29	8526-8528	of	_
39-30	8529-8532	BLA	_
39-31	8533-8536	and	_
39-32	8537-8540	CMA	_
39-33	8541-8550	complexes	_
39-34	8551-8553	as	_
39-35	8554-8564	predictors	_
39-36	8565-8566	[	_
39-37	8567-8575	Aghajani	_
39-38	8576-8578	et	_
39-39	8579-8582	al.	_
39-40	8583-8584	,	_
39-41	8585-8589	2016	_
39-42	8590-8591	;	_
39-43	8592-8597	Brown	_
39-44	8598-8600	et	_
39-45	8601-8604	al.	_
39-46	8605-8606	,	_
39-47	8607-8611	2014	_
39-48	8612-8613	;	_
39-49	8614-8617	Roy	_
39-50	8618-8620	et	_
39-51	8621-8624	al.	_
39-52	8625-8626	,	_
39-53	8627-8631	2013	_
39-54	8632-8633	]	_
39-55	8634-8635	.	_

40-1	8636-8646	Temporally	_
40-2	8647-8655	filtered	_
40-3	8656-8662	signal	_
40-4	8663-8667	from	_
40-5	8668-8671	the	_
40-6	8672-8677	white	_
40-7	8678-8684	matter	_
40-8	8685-8688	and	_
40-9	8689-8702	cerebrospinal	_
40-10	8703-8708	fluid	_
40-11	8709-8710	(	_
40-12	8711-8714	see	_
40-13	8715-8725	Supporting	_
40-14	8726-8737	Information	_
40-15	8738-8741	for	_
40-16	8742-8749	details	_
40-17	8750-8751	)	_
40-18	8752-8753	,	_
40-19	8754-8756	as	_
40-20	8757-8761	well	_
40-21	8762-8764	as	_
40-22	8765-8768	six	_
40-23	8769-8775	motion	_
40-24	8776-8786	parameters	_
40-25	8787-8790	and	_
40-26	8791-8801	parameters	_
40-27	8802-8810	obtained	_
40-28	8811-8815	from	_
40-29	8816-8819	the	_
40-30	8820-8826	motion	_
40-31	8827-8836	censoring	_
40-32	8837-8846	procedure	_
40-33	8847-8848	(	_
40-34	8849-8852	see	_
40-35	8853-8863	Supporting	_
40-36	8864-8875	Information	_
40-37	8876-8879	for	_
40-38	8880-8887	details	_
40-39	8888-8889	)	_
40-40	8890-8891	,	_
40-41	8892-8896	were	_
40-42	8897-8901	also	_
40-43	8902-8910	included	_
40-44	8911-8913	in	_
40-45	8914-8918	this	_
40-46	8919-8924	model	_
40-47	8925-8927	as	_
40-48	8928-8938	covariates	_
40-49	8939-8941	of	_
40-50	8942-8944	no	_
40-51	8945-8953	interest	_
40-52	8954-8956	to	_
40-53	8957-8964	correct	_
40-54	8965-8968	for	_
40-55	8969-8982	physiological	_
40-56	8983-8986	and	_
40-57	8987-9001	motion‐related	_
40-58	9002-9010	variance	_
40-59	9011-9012	[	_
40-60	9013-9021	Aghajani	_
40-61	9022-9024	et	_
40-62	9025-9028	al.	_
40-63	9029-9030	,	_
40-64	9031-9035	2016	_
40-65	9036-9037	]	_
40-66	9038-9039	.	_

41-1	9040-9044	This	_
41-2	9045-9053	resulted	_
41-3	9054-9056	in	_
41-4	9057-9067	individual	_
41-5	9068-9081	subject–level	_
41-6	9082-9094	connectivity	_
41-7	9095-9099	maps	_
41-8	9100-9110	comprising	_
41-9	9111-9117	voxels	_
41-10	9118-9128	throughout	_
41-11	9129-9132	the	_
41-12	9133-9138	brain	_
41-13	9139-9143	that	_
41-14	9144-9153	exhibited	_
41-15	9154-9157	iFC	_
41-16	9158-9159	(	_
41-17	9160-9164	i.e.	_
41-18	9165-9166	,	_
41-19	9167-9175	temporal	_
41-20	9176-9183	partial	_
41-21	9184-9196	correlations	_
41-22	9197-9198	)	_
41-23	9199-9203	with	_
41-24	9204-9208	each	_
41-25	9209-9217	amygdala	_
41-26	9218-9227	subregion	_
41-27	9228-9229	,	_
41-28	9230-9240	accounting	_
41-29	9241-9244	for	_
41-30	9245-9248	the	_
41-31	9249-9262	relationships	_
41-32	9263-9267	with	_
41-33	9268-9271	the	_
41-34	9272-9277	other	_
41-35	9278-9287	subregion	_
41-36	9288-9289	(	_
41-37	9290-9294	i.e.	_
41-38	9295-9296	,	_
41-39	9297-9303	unique	_
41-40	9304-9322	subregion‐specific	_
41-41	9323-9335	connectivity	_
41-42	9336-9340	maps	_
41-43	9341-9342	)	_
41-44	9343-9344	[	_
41-45	9345-9353	Aghajani	_
41-46	9354-9356	et	_
41-47	9357-9360	al.	_
41-48	9361-9362	,	_
41-49	9363-9367	2016	_
41-50	9368-9369	;	_
41-51	9370-9375	Brown	_
41-52	9376-9378	et	_
41-53	9379-9382	al.	_
41-54	9383-9384	,	_
41-55	9385-9389	2014	_
41-56	9390-9391	;	_
41-57	9392-9395	Roy	_
41-58	9396-9398	et	_
41-59	9399-9402	al.	_
41-60	9403-9404	,	_
41-61	9405-9409	2013	_
41-62	9410-9411	]	_
41-63	9412-9413	.	_

42-1	9414-9427	Subject‐level	_
42-2	9428-9431	iFC	_
42-3	9432-9436	maps	_
42-4	9437-9439	of	_
42-5	9440-9443	BLA	_
42-6	9444-9447	and	_
42-7	9448-9451	CMA	_
42-8	9452-9462	subregions	_
42-9	9463-9467	were	_
42-10	9468-9472	then	_
42-11	9473-9476	fed	_
42-12	9477-9481	into	_
42-13	9482-9483	a	_
42-14	9484-9495	group‐level	_
42-15	9496-9509	mixed‐effects	_
42-16	9510-9513	GLM	_
42-17	9514-9522	analysis	_
42-18	9523-9534	implemented	_
42-19	9535-9537	in	_
42-20	9538-9542	FEAT	_
42-21	9543-9544	(	_
42-22	9545-9549	with	_
42-23	9550-9555	FLAME	_
42-24	9556-9559	and	_
42-25	9560-9569	automatic	_
42-26	9570-9577	outlier	_
42-27	9578-9590	de‐weighting	_
42-28	9591-9592	)	_
42-29	9593-9594	,	_
42-30	9595-9597	in	_
42-31	9598-9603	order	_
42-32	9604-9606	to	_
42-33	9607-9614	average	_
42-34	9615-9620	these	_
42-35	9621-9634	subject‐level	_
42-36	9635-9639	maps	_
42-37	9640-9643	and	_
42-38	9644-9650	create	_
42-39	9651-9662	group‐level	_
42-40	9663-9675	connectivity	_
42-41	9676-9680	maps	_
42-42	9681-9683	of	_
42-43	9684-9687	BLA	_
42-44	9688-9691	and	_
42-45	9692-9695	CMA	_
42-46	9696-9705	complexes	_
42-47	9706-9707	[	_
42-48	9708-9716	Aghajani	_
42-49	9717-9719	et	_
42-50	9720-9723	al.	_
42-51	9724-9725	,	_
42-52	9726-9730	2016	_
42-53	9731-9732	;	_
42-54	9733-9738	Brown	_
42-55	9739-9741	et	_
42-56	9742-9745	al.	_
42-57	9746-9747	,	_
42-58	9748-9752	2014	_
42-59	9753-9754	;	_
42-60	9755-9758	Roy	_
42-61	9759-9761	et	_
42-62	9762-9765	al.	_
42-63	9766-9767	,	_
42-64	9768-9772	2013	_
42-65	9773-9774	]	_
42-66	9775-9776	.	_

43-1	9777-9787	Individual	_
43-2	9788-9799	participant	_
43-3	9800-9802	's	_
43-4	9803-9812	affective	_
43-5	9813-9814	,	_
43-6	9815-9828	interpersonal	_
43-7	9829-9830	,	_
43-8	9831-9834	and	_
43-9	9835-9845	behavioral	_
43-10	9846-9851	trait	_
43-11	9852-9860	scorings	_
43-12	9861-9865	were	_
43-13	9866-9880	simultaneously	_
43-14	9881-9888	entered	_
43-15	9889-9891	in	_
43-16	9892-9896	this	_
43-17	9897-9908	group‐level	_
43-18	9909-9912	GLM	_
43-19	9913-9921	analysis	_
43-20	9922-9924	as	_
43-21	9925-9935	predictors	_
43-22	9936-9937	(	_
43-23	9938-9942	with	_
43-24	9943-9946	age	_
43-25	9947-9950	and	_
43-26	9951-9953	IQ	_
43-27	9954-9956	as	_
43-28	9957-9967	covariates	_
43-29	9968-9969	)	_
43-30	9970-9971	,	_
43-31	9972-9974	in	_
43-32	9975-9980	order	_
43-33	9981-9983	to	_
43-34	9984-9990	reveal	_
43-35	9991-9994	how	_
43-36	9995-10005	individual	_
43-37	10006-10016	variations	_
43-38	10017-10019	in	_
43-39	10020-10032	psychopathic	_
43-40	10033-10039	traits	_
43-41	10040-10046	relate	_
43-42	10047-10049	to	_
43-43	10050-10053	iFC	_
43-44	10054-10062	profiles	_
43-45	10063-10065	of	_
43-46	10066-10069	BLA	_
43-47	10070-10073	and	_
43-48	10074-10077	CMA	_
43-49	10078-10088	subregions	_
43-50	10089-10090	.	_

44-1	10091-10099	Entering	_
44-2	10100-10103	all	_
44-3	10104-10109	three	_
44-4	10110-10115	trait	_
44-5	10116-10126	dimensions	_
44-6	10127-10129	in	_
44-7	10130-10133	the	_
44-8	10134-10138	same	_
44-9	10139-10150	group‐level	_
44-10	10151-10154	GLM	_
44-11	10155-10160	takes	_
44-12	10161-10165	into	_
44-13	10166-10173	account	_
44-14	10174-10179	their	_
44-15	10180-10188	possible	_
44-16	10189-10195	shared	_
44-17	10196-10204	variance	_
44-18	10205-10206	,	_
44-19	10207-10211	thus	_
44-20	10212-10221	revealing	_
44-21	10222-10225	BLA	_
44-22	10226-10229	and	_
44-23	10230-10233	CMA	_
44-24	10234-10246	connectivity	_
44-25	10247-10255	patterns	_
44-26	10256-10264	uniquely	_
44-27	10265-10275	associated	_
44-28	10276-10280	with	_
44-29	10281-10285	each	_
44-30	10286-10288	of	_
44-31	10289-10292	the	_
44-32	10293-10298	three	_
44-33	10299-10304	trait	_
44-34	10305-10315	dimensions	_
44-35	10316-10317	.	_

45-1	10318-10322	That	_
45-2	10323-10325	is	_
45-3	10326-10327	,	_
45-4	10328-10342	trait‐specific	_
45-5	10343-10351	variance	_
45-6	10352-10354	in	_
45-7	10355-10364	amygdalar	_
45-8	10365-10368	iFC	_
45-9	10369-10373	over	_
45-10	10374-10377	and	_
45-11	10378-10383	above	_
45-12	10384-10388	what	_
45-13	10389-10392	can	_
45-14	10393-10395	be	_
45-15	10396-10405	explained	_
45-16	10406-10408	by	_
45-17	10409-10412	the	_
45-18	10413-10418	other	_
45-19	10419-10425	traits	_
45-20	10426-10427	.	_

46-1	10428-10437	Following	_
46-2	10438-10445	earlier	_
46-3	10446-10450	work	_
46-4	10451-10453	on	_
46-5	10454-10462	amygdala	_
46-6	10463-10474	subregional	_
46-7	10475-10478	iFC	_
46-8	10479-10487	patterns	_
46-9	10488-10489	[	_
46-10	10490-10498	Aghajani	_
46-11	10499-10501	et	_
46-12	10502-10505	al.	_
46-13	10506-10507	,	_
46-14	10508-10512	2016	_
46-15	10513-10514	;	_
46-16	10515-10520	Brown	_
46-17	10521-10523	et	_
46-18	10524-10527	al.	_
46-19	10528-10529	,	_
46-20	10530-10534	2014	_
46-21	10535-10536	;	_
46-22	10537-10540	Roy	_
46-23	10541-10543	et	_
46-24	10544-10547	al.	_
46-25	10548-10549	,	_
46-26	10550-10554	2009	_
46-27	10555-10556	;	_
46-28	10557-10562	Singh	_
46-29	10563-10565	et	_
46-30	10566-10569	al.	_
46-31	10570-10571	,	_
46-32	10572-10576	2015	_
46-33	10577-10578	]	_
46-34	10579-10580	,	_
46-35	10581-10584	the	_
46-36	10585-10594	resulting	_
46-37	10595-10606	statistical	_
46-38	10607-10611	maps	_
46-39	10612-10616	were	_
46-40	10617-10620	all	_
46-41	10621-10630	corrected	_
46-42	10631-10634	for	_
46-43	10635-10643	multiple	_
46-44	10644-10655	comparisons	_
46-45	10656-10661	using	_
46-46	10662-10675	cluster‐based	_
46-47	10676-10686	correction	_
46-48	10687-10691	with	_
46-49	10692-10699	initial	_
46-50	10700-10707	cluster	_
46-51	10708-10715	forming	_
46-52	10716-10725	threshold	_
46-53	10726-10728	of	_
46-54	10729-10730	Z	_
46-55	10731-10732	>	_
46-56	10733-10736	2.3	_
46-57	10737-10740	and	_
46-58	10741-10748	cluster	_
46-59	10749-10755	extent	_
46-60	10756-10765	threshold	_
46-61	10766-10768	of	_
46-62	10769-10770	P	_
46-63	10771-10772	<	_
46-64	10773-10777	0.05	_
46-65	10778-10779	,	_
46-66	10780-10785	which	_
46-67	10786-10791	tends	_
46-68	10792-10794	to	_
46-69	10795-10805	adequately	_
46-70	10806-10813	balance	_
46-71	10814-10817	the	_
46-72	10818-10829	propagation	_
46-73	10830-10832	of	_
46-74	10833-10838	false	_
46-75	10839-10848	positives	_
46-76	10849-10852	and	_
46-77	10853-10858	false	_
46-78	10859-10868	negatives	_
46-79	10869-10870	[	_
46-80	10871-10878	Bennett	_
46-81	10879-10881	et	_
46-82	10882-10885	al.	_
46-83	10886-10887	,	_
46-84	10888-10892	2009	_
46-85	10893-10894	;	_
46-86	10895-10904	Jenkinson	_
46-87	10905-10907	et	_
46-88	10908-10911	al.	_
46-89	10912-10913	,	_
46-90	10914-10918	2012	_
46-91	10919-10920	;	_
46-92	10921-10930	Lieberman	_
46-93	10931-10934	and	_
46-94	10935-10945	Cunningham	_
46-95	10946-10947	,	_
46-96	10948-10952	2009	_
46-97	10953-10954	]	_
46-98	10955-10956	.	_

